{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Galactose : Questions médicales les plus fréquentes",
"headline": "Galactose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Galactose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-04",
"dateModified": "2025-03-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Galactose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hexose",
"url": "https://questionsmedicales.fr/mesh/D006601",
"about": {
"@type": "MedicalCondition",
"name": "Hexose",
"code": {
"@type": "MedicalCode",
"code": "D006601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.947.875.359"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Galactose",
"alternateName": "Galactose",
"code": {
"@type": "MedicalCode",
"code": "D005690",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tilo Biedermann",
"url": "https://questionsmedicales.fr/author/Tilo%20Biedermann",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany."
}
},
{
"@type": "Person",
"name": "Eva Morava",
"url": "https://questionsmedicales.fr/author/Eva%20Morava",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatrics and Metabolic Center, University Hospitals Leuven, Leuven, Belgium. peter.witters@uzleuven.be."
}
},
{
"@type": "Person",
"name": "Scott P Commins",
"url": "https://questionsmedicales.fr/author/Scott%20P%20Commins",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, North Carolina."
}
},
{
"@type": "Person",
"name": "Marianne van Hage",
"url": "https://questionsmedicales.fr/author/Marianne%20van%20Hage",
"affiliation": {
"@type": "Organization",
"name": "Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and University Hospital, Stockholm, Sweden."
}
},
{
"@type": "Person",
"name": "Michael Levin",
"url": "https://questionsmedicales.fr/author/Michael%20Levin",
"affiliation": {
"@type": "Organization",
"name": "Division of Paediatric Allergy, University of Cape Town, Cape Town, South Africa. Electronic address: Michael.levin@uct.ac.za."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Accelerometry measures of physical activity and sedentary behavior: Associations with cognitive functioning in MS.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37690438",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.msard.2023.104963"
}
},
{
"@type": "ScholarlyArticle",
"name": "Wrist-Worn Accelerometry, Aging, and Gait Speed in the Baltimore Longitudinal Study of Aging.",
"datePublished": "2022-10-13",
"url": "https://questionsmedicales.fr/article/36241170",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1123/japa.2022-0156"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adapting the Intensity Gradient for Use with Count-Based Accelerometry Data in Children and Adolescents.",
"datePublished": "2024-05-10",
"url": "https://questionsmedicales.fr/article/38793873",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s24103019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physical Activity Assessed by Wrist and Thigh Worn Accelerometry and Associations with Cardiometabolic Health.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37687813",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23177353"
}
},
{
"@type": "ScholarlyArticle",
"name": "Criterion validity of wrist accelerometry for assessing energy intake via the intake-balance technique.",
"datePublished": "2023-09-25",
"url": "https://questionsmedicales.fr/article/37749645",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12966-023-01515-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Glucides",
"item": "https://questionsmedicales.fr/mesh/D002241"
},
{
"@type": "ListItem",
"position": 3,
"name": "Sucres",
"item": "https://questionsmedicales.fr/mesh/D000073893"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oses",
"item": "https://questionsmedicales.fr/mesh/D009005"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hexose",
"item": "https://questionsmedicales.fr/mesh/D006601"
},
{
"@type": "ListItem",
"position": 6,
"name": "Galactose",
"item": "https://questionsmedicales.fr/mesh/D005690"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Galactose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Galactose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Galactose",
"description": "Comment diagnostiquer une intolérance à la galactose ?\nQuels tests sont utilisés pour détecter la galactosémie ?\nQuels symptômes indiquent un problème avec la galactose ?\nComment évaluer le métabolisme de la galactose ?\nQuel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?",
"url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Accelerometry&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Galactose",
"description": "Quels sont les symptômes d'une galactosémie ?\nComment se manifeste l'intolérance au galactose ?\nQuels signes indiquent une surcharge de galactose ?\nLa galactose peut-elle causer des problèmes oculaires ?\nQuels symptômes neurologiques sont associés à la galactosémie ?",
"url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Accelerometry&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Galactose",
"description": "Comment prévenir la galactosémie chez les nouveau-nés ?\nLes femmes enceintes doivent-elles se soucier de la galactose ?\nQuels aliments éviter pour prévenir l'intolérance au galactose ?\nLe dépistage génétique est-il utile pour la galactosémie ?\nComment sensibiliser à la galactosémie ?",
"url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Accelerometry&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Galactose",
"description": "Quel est le traitement principal de la galactosémie ?\nPeut-on utiliser des suppléments pour la galactosémie ?\nComment gérer l'intolérance au galactose ?\nY a-t-il des médicaments pour traiter la galactosémie ?\nComment surveiller l'évolution d'une galactosémie ?",
"url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Accelerometry&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Galactose",
"description": "Quelles complications peuvent survenir avec la galactosémie ?\nLa galactosémie peut-elle affecter le développement physique ?\nQuels risques neurologiques sont associés à la galactosémie ?\nComment la galactosémie affecte-t-elle le foie ?\nY a-t-il des complications à long terme de la galactosémie ?",
"url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Accelerometry&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Galactose",
"description": "Quels sont les facteurs de risque de la galactosémie ?\nLa consanguinité augmente-t-elle le risque de galactosémie ?\nLes femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?\nLes populations spécifiques sont-elles plus à risque ?\nComment les tests génétiques aident-ils à évaluer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Accelerometry&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intolérance à la galactose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test de tolérance au galactose et des analyses sanguines peuvent confirmer l'intolérance."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter la galactosémie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des dosages de galactose dans le sang sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec la galactose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, les vomissements et la jaunisse peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment évaluer le métabolisme de la galactose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme et des analyses enzymatiques peuvent évaluer la dégradation de la galactose."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cette enzyme est cruciale pour le métabolisme de la galactose et son absence cause des troubles."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une galactosémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent vomissements, diarrhée, jaunisse et retard de croissance."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'intolérance au galactose ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs abdominales, des ballonnements et des diarrhées après ingestion."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surcharge de galactose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la fatigue, des troubles neurologiques et des problèmes hépatiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "La galactose peut-elle causer des problèmes oculaires ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une accumulation de galactose peut entraîner des cataractes et d'autres problèmes oculaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes neurologiques sont associés à la galactosémie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles du développement, des convulsions et des retards mentaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir la galactosémie chez les nouveau-nés ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage néonatal permet de détecter la galactosémie et d'initier un traitement précoce."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se soucier de la galactose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent surveiller leur consommation de galactose, surtout si des antécédents familiaux existent."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour prévenir l'intolérance au galactose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les produits laitiers, les légumineuses et certains fruits comme les cerises."
}
},
{
"@type": "Question",
"name": "Le dépistage génétique est-il utile pour la galactosémie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut identifier les porteurs et les personnes à risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser à la galactosémie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des ressources éducatives peuvent aider à sensibiliser le public."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de la galactosémie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à suivre un régime strict sans galactose, excluant les produits laitiers."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des suppléments pour la galactosémie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments de calcium et de vitamine D peuvent être nécessaires en raison d'un régime restrictif."
}
},
{
"@type": "Question",
"name": "Comment gérer l'intolérance au galactose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments contenant du galactose et consulter un diététicien pour un suivi."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments pour traiter la galactosémie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques, le régime est le traitement principal."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'évolution d'une galactosémie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers des niveaux de galactose et des évaluations cliniques sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la galactosémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des problèmes hépatiques, des cataractes et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La galactosémie peut-elle affecter le développement physique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner un retard de croissance et des problèmes de développement physique."
}
},
{
"@type": "Question",
"name": "Quels risques neurologiques sont associés à la galactosémie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des convulsions, des retards mentaux et des troubles du comportement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment la galactosémie affecte-t-elle le foie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer une hépatomégalie et des lésions hépatiques dues à l'accumulation de galactose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme de la galactosémie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications à long terme incluent des troubles cognitifs et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la galactosémie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de galactosémie et certaines mutations génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "La consanguinité augmente-t-elle le risque de galactosémie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consanguinité peut augmenter le risque de transmission de la galactosémie."
}
},
{
"@type": "Question",
"name": "Les femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent transmettre le gène à leurs enfants, augmentant le risque de la maladie."
}
},
{
"@type": "Question",
"name": "Les populations spécifiques sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines populations, comme les Ashkénazes, ont un risque plus élevé de galactosémie."
}
},
{
"@type": "Question",
"name": "Comment les tests génétiques aident-ils à évaluer le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests génétiques peuvent identifier les porteurs et évaluer le risque de transmission."
}
}
]
}
]
}
Cognitive dysfunction is a pervasive symptom of multiple sclerosis (MS). Correlational evidence on the relationships between physical activity, sedentary behavior, and cognition has been mixed and lim...
We analyzed baseline accelerometry and neuropsychological data (n = 80) from a randomized controlled trial of pedometer tracking. Using partial least squares regression (PLSR), we built three models t...
The latent component was significant for working memory/processing speed but was not significant for visual memory and verbal memory after Bonferroni correction. Working memory/processing speed was po...
These findings suggest that increasing overall energy expenditure through walking and MVPA, while decreasing prolonged sedentary time may positively benefit working memory/processing speed in people w...
This RCT #NCT03244696 was registered on Clinicaltrials.gov (https://www....
gov/ct2/show/NCT03244696)....
Wrist-worn accelerometry metrics are not well defined in older adults. Accelerometry data from 720 participants (mean age 70 years, 55% women) were summarized into (a) total activity counts per day, (...
The intensity gradient is a new cutpoint-free metric that was developed to quantify physical activity (PA) measured using accelerometers. This metric was developed for use with the ENMO (Euclidean nor...
Physical activity is increasingly being captured by accelerometers worn on different body locations. The aim of this study was to examine the associations between physical activity volume (average acc...
Intake-balance assessments measure energy intake (EI) by summing energy expenditure (EE) with concurrent change in energy storage (ΔES). Prior work has not examined the validity of such calculations w...
Healthy adults (n = 24) completed two 14-day measurement periods while wearing an ActiGraph accelerometer on the non-dominant wrist. During each period, criterion values of EI were determined based on...
Mean bias for the three best accelerometry-based methods ranged from -167 to 124 kcal/day, versus -104 to 134 kcal/day for the non-accelerometry-based methods. The same three accelerometry-based metho...
Accelerometry-based intake-balance methods have promise for advancing EI assessment, but ongoing refinement is necessary. We provide an R package to facilitate implementation and refinement of acceler...
Wrist-worn consumer sleep technologies (CST) that contain accelerometers (ACC) and photoplethysmography (PPG) are increasingly common and hold great potential to function as out-of-clinic (OOC) sleep ...
Remote health monitoring has become increasingly important, especially in aging populations. We aimed to identify tasks that are sensitive to age-related changes in balance during fully remote, at-hom...
Physical activity in paediatric and young adult patients suffering from inflammatory bowel disease (IBD) may play an important role in the overall health status. However, physical activity in these pa...
We recruited Danish patients with IBD aged 10-20 years in clinical remission and with a faecal calprotectin below 200 µg/mg. Physical activity was assessed using tri-axial wrist accelerometry over sev...
We included 61 patients with a median age of 17 years [Inter Quartile Range, IQR 14-19]. The total volume of activity expressed as average acceleration (ENMO) per day was 31.5 mg (95% CI 29.1-33.9). T...
We collected tri-axial accelerometry in young patients with IBD in clinical remission, and described their level of physical activity by the conventional ENMO measure. We found no statistically signif...
The Gait&Balance (G&B) App has produced valid and reliable measures of gait and balance in young healthy adults but has not been tested in older adults....
In healthy middle-to-older aged adults, are G&B App measurements sensitive to age, valid against clinical and kinematic measures, and reliable?...
Healthy participants (n = 34, 14 male, 42-94 years) completed the G&B App protocol three times within a single session. 3D kinematics were collected concurrently. Clinical balance measures were collec...
During quiet stance on a compliant surface, the G&B App was sensitive to age-related differences not detectable with the mCTSIB. During walking tasks, there was adequate convergent validity between th...
The G&B App was sensitive to age-related differences in balance not detectable with clinical measurement. It provides valid and reliable measures of postural stability, step length, step time, and per...
The aim of this study was to compare energy expenditure (EE) predicted by accelerometery (EE...
Twenty-four participants (12 with stroke and 12 healthy controls) performed a six-minute walk test (6MWT) during which EE...
The median EE...
The accuracy of the predicted EE, based on the accelerometer and the equations proposed by Bouten et al., was low in individuals with hemiparesis and impaired gait. This combination (sensor and Bouten...